Drugs / LAIV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01797029 | Feb 2013 → Sep 2014 | influenza | PATH | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LAIV | “This is a single center, multi-site, double-blind, parallel group, placebo-controlled trial of the clinical efficacy of trivalent Serum Institute of India, Ltd....” NCT01797029 ↗ |
| Modality | Vaccine | “live attenuated influenza vaccine (LAIV)” NCT01797029 ↗ |
| Route | Intranasal | “to receive one intranasal dose of LAIV or placebo” PMID 27746226 ↗ Oct 2016 |